COHERUS BIOSCIENCES INC. - COMMON STOCK

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

08 Nov 2023 09:08:07 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

07 Nov 2023 08:46:38 By NetDania Notify

Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights

06 Nov 2023 15:07:41 By Nasdaq GlobeNewswire

Coherus Presents Data from Next-generation Immuno-oncology Programs at 38th Annual Meeting of Society for Immunotherapy of Cancer (SITC)

03 Nov 2023 07:30:00 By Nasdaq GlobeNewswire

Coherus BioSciences to Participate at Upcoming November Investor Conferences

02 Nov 2023 19:00:08 By Nasdaq GlobeNewswire

Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023

30 Oct 2023 17:00:00 By Nasdaq GlobeNewswire

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

27 Oct 2023 14:07:20 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

27 Oct 2023 08:48:35 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

26 Oct 2023 08:45:14 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

25 Oct 2023 08:46:13 By NetDania Notify

Coherus BioSciences Announces New Employment Inducement Grants

24 Oct 2023 18:41:27 By Nasdaq GlobeNewswire

Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

14 Oct 2023 11:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 Oct 2023 10:23:26 By NetDania Notify

Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™

05 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

04 Oct 2023 08:59:51 By NetDania Notify

CIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in First Year of Launch

04 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

03 Oct 2023 08:45:14 By NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

02 Oct 2023 14:02:53 By NetDania Notify

Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day

02 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

Coherus Announces Three Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

27 Sep 2023 08:10:29 By Nasdaq GlobeNewswire